<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Immunology Product Guide &#187; photopheresis system</title>
	<atom:link href="http://www.immunologyproductguide.com/blog/tag/photopheresis-system/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.immunologyproductguide.com/blog</link>
	<description>A comprehensive guide to immunology products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 10:09:04 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Therakos gets CE Mark for its photopheresis system</title>
		<link>http://www.immunologyproductguide.com/blog/2008/04/16/therakos-gets-ce-mark-for-its-photopheresis-system/</link>
		<comments>http://www.immunologyproductguide.com/blog/2008/04/16/therakos-gets-ce-mark-for-its-photopheresis-system/#comments</comments>
		<pubDate>Wed, 16 Apr 2008 16:29:20 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Immune System Disorders]]></category>
		<category><![CDATA[chronic graft-versus-host]]></category>
		<category><![CDATA[cutaneous T-cell lymphoma]]></category>
		<category><![CDATA[photopheresis system]]></category>
		<category><![CDATA[Therakos]]></category>
		<category><![CDATA[THERAKOS CELLEX]]></category>

		<guid isPermaLink="false">http://www.immunologyproductguide.com/blog/2008/04/16/therakos-gets-ce-mark-for-its-photopheresis-system/</guid>
		<description><![CDATA[Therakos Inc, a pioneer for more than 20 years in immune cell therapy, has announced the receipt of a CE Mark in Europe for its THERAKOS(TM) CELLEX(TM) Photopheresis System. The THERAKOS CELLEX Photopheresis System is used for the treatment of immune-mediated diseases, such as acute or chronic graft-versus-host disease (GvHD) and cutaneous T-cell lymphoma (CTCL). [...]]]></description>
			<content:encoded><![CDATA[<p>Therakos Inc, a pioneer for more than 20 years in immune cell therapy, has announced the receipt of a CE Mark in Europe for its THERAKOS(TM) CELLEX(TM) Photopheresis System. The THERAKOS CELLEX Photopheresis System is used for the treatment of immune-mediated diseases, such as acute or chronic graft-versus-host disease (GvHD) and cutaneous T-cell lymphoma (CTCL). The product offers state-of-the-art technology in a single, integrated, closed system device that allows a sole operator to customize a patient&#8217;s treatment and immediately adjust parameters to respond to changes in the patient&#8217;s condition.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.immunologyproductguide.com/blog/2008/04/16/therakos-gets-ce-mark-for-its-photopheresis-system/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
